Pharmena S.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was PLN 0.166 million compared to PLN 0.161 million a year ago. Net loss was PLN 0.725 million compared to PLN 0.633 million a year ago.

Basic loss per share from continuing operations was PLN 0.24 compared to PLN 0.19 a year ago. Diluted loss per share from continuing operations was PLN 0.24 compared to PLN 0.19 a year ago. Basic loss per share was PLN 0.07 compared to PLN 0.06 a year ago.

Diluted loss per share was PLN 0.07 compared to PLN 0.06 a year ago.